Inspire Medical Systems, Inc. (INSP)
Automate Your Wheel Strategy on INSP
With Tiblio's Option Bot, you can configure your own wheel strategy including INSP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INSP
- Rev/Share 28.2843
- Book/Share 21.4038
- PB 6.4591
- Debt/Equity 0.0495
- CurrentRatio 9.0071
- ROIC 0.069
- MktCap 4077531675.0
- FreeCF/Share 2.6546
- PFCF 51.7132
- PE 61.7441
- Debt/Assets 0.0431
- DivYield 0
- ROE 0.1
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
Published: May 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students across the United States who are committed to pursuing a career in medicine.
Read More
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.
Read More
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D.
Published: April 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that two leading physicians in the field of sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire in Vice President, Senior Medical Director roles, effective April 21 and June 2 respectively.
Read More
Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm
Published: February 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire Medical”) on behalf of the company's long-term shareholders.
Read More
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth quarter.
Read More
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital …
Read More
Inspire Medical's Earnings Surge in Q4
Published: February 10, 2025 by: The Motley Fool
Sentiment: Positive
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.
Read More
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024
Read More
About Inspire Medical Systems, Inc. (INSP)
- IPO Date 2018-05-03
- Website https://www.inspiresleep.com
- Industry Medical - Devices
- CEO Mr. Timothy P. Herbert
- Employees 1246